Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in BMC Cancer

Retrieve available abstracts of 157 articles:
HTML format
Text format



Single Articles


    December 2017
  1. QUINTANILHA JCF, Visacri MB, Amaral LS, Lima CSP, et al
    Leukocytoclastic vasculitis complicating cisplatin + radiation treatment for laryngeal cancer: a case report.
    BMC Cancer. 2017;17:831.
    PubMed     Text format     Abstract available


  2. KANO K, Aoyama T, Nakajima T, Maezawa Y, et al
    Prediction of postoperative inflammatory complications after esophageal cancer surgery based on early changes in the C-reactive protein level in patients who received perioperative steroid therapy and enhanced recovery after surgery care: a retrospect
    BMC Cancer. 2017;17:812.
    PubMed     Text format     Abstract available


    November 2017
  3. SHAIKH MH, Khan AI, Sadat A, Chowdhury AH, et al
    Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh.
    BMC Cancer. 2017;17:792.
    PubMed     Text format     Abstract available


  4. ZHANG LL, Zhou GQ, Qi ZY, He XJ, et al
    Patient- and treatment-related risk factors associated with neck muscle spasm in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy.
    BMC Cancer. 2017;17:788.
    PubMed     Text format     Abstract available


  5. HIGUCHI Y, Motoki T, Ishida H, Kanamitsu K, et al
    Sorafenib treatment for papillary thyroid carcinoma with diffuse lung metastases in a child with autism spectrum disorder: a case report.
    BMC Cancer. 2017;17:775.
    PubMed     Text format     Abstract available


  6. MURAKAMI M, Otsuka K, Goto S, Ariyoshi T, et al
    Thoracoscopic and hand assisted laparoscopic esophagectomy with radical lymph node dissection for esophageal squamous cell carcinoma in the left lateral decubitus position: a single center retrospective analysis of 654 patients.
    BMC Cancer. 2017;17:748.
    PubMed     Text format     Abstract available


  7. JIN Y, Liu M, Cheng L, Chen L, et al
    Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report.
    BMC Cancer. 2017;17:735.
    PubMed     Text format     Abstract available


  8. DI L, Fu KI, Xie R, Wu X, et al
    A modified endoscopic submucosal dissection for a superficial hypopharyngeal cancer: a case report and technical discussion.
    BMC Cancer. 2017;17:712.
    PubMed     Text format     Abstract available


    October 2017
  9. ROCHA TAH, Thomaz EBAF, da Silva NC, de Sousa Queiroz RC, et al
    Oral primary care: an analysis of its impact on the incidence and mortality rates of oral cancer.
    BMC Cancer. 2017;17:706.
    PubMed     Text format     Abstract available


  10. NIE X, Tan Z, Ge M
    Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
    BMC Cancer. 2017;17:702.
    PubMed     Text format     Abstract available


  11. YAN DF, Zhang WB, Ke SB, Zhao F, et al
    The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
    BMC Cancer. 2017;17:678.
    PubMed     Text format     Abstract available


    September 2017
  12. YANG L, Xia L, Wang Y, He S, et al
    Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.
    BMC Cancer. 2017;17:628.
    PubMed     Text format     Abstract available


  13. DYCKHOFF G, Plinkert PK, Ramroth H
    A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients.
    BMC Cancer. 2017;17:609.
    PubMed     Text format     Abstract available


    August 2017
  14. DU L, Zhang XX, Feng LC, Qu BL, et al
    Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas.
    BMC Cancer. 2017;17:582.
    PubMed     Text format     Abstract available


  15. CHRISTENSEN A, Kiss K, Lelkaitis G, Juhl K, et al
    Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.
    BMC Cancer. 2017;17:572.
    PubMed     Text format     Abstract available


  16. LI Y, Chen QY, Tang LQ, Liu LT, et al
    Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study.
    BMC Cancer. 2017;17:567.
    PubMed     Text format     Abstract available


  17. VAN VULPEN JK, Siersema PD, van Hillegersberg R, Nieuwenhuijzen GAP, et al
    Physical ExeRcise Following Esophageal Cancer Treatment (PERFECT) study: design of a randomized controlled trial.
    BMC Cancer. 2017;17:552.
    PubMed     Text format     Abstract available


  18. HUANG H, Wang XP, Li XH, Chen H, et al
    Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.
    BMC Cancer. 2017;17:544.
    PubMed     Text format     Abstract available


    July 2017
  19. HAAG GM, Stocker G, Quidde J, Jaeger D, et al
    Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.
    BMC Cancer. 2017;17:509.
    PubMed     Text format     Abstract available


  20. LIANG SB, Teng JJ, Hu XF, Yang XL, et al
    Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    BMC Cancer. 2017;17:506.
    PubMed     Text format     Abstract available


  21. ZHAO W, Mo Y, Wang S, Midorikawa K, et al
    Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
    BMC Cancer. 2017;17:489.
    PubMed     Text format     Abstract available


  22. SERVAGI-VERNAT S, Crehange G, Bonnetain F, Mertens C, et al
    Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE).
    BMC Cancer. 2017;17:483.
    PubMed     Text format     Abstract available


  23. FU X, Shen C, Wang H, Chen F, et al
    Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
    BMC Cancer. 2017;17:479.
    PubMed     Text format     Abstract available


  24. SU Y, Yu QH, Wang XY, Yu LP, et al
    JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
    BMC Cancer. 2017;17:477.
    PubMed     Text format     Abstract available


  25. RUMLEY CN, Lee MT, Holloway L, Rai R, et al
    Multiparametric magnetic resonance imaging in mucosal primary head and neck cancer: a prospective imaging biomarker study.
    BMC Cancer. 2017;17:475.
    PubMed     Text format     Abstract available


    June 2017
  26. YU X, Li W, Xia Z, Xie L, et al
    Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis.
    BMC Cancer. 2017;17:449.
    PubMed     Text format     Abstract available


  27. TANG H, Tan L, Shen Y, Wang H, et al
    CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous
    BMC Cancer. 2017;17:450.
    PubMed     Text format     Abstract available


  28. IMANISHI Y, Ozawa H, Sakamoto K, Fujii R, et al
    Clinical outcomes of transoral videolaryngoscopic surgery for hypopharyngeal and supraglottic cancer.
    BMC Cancer. 2017;17:445.
    PubMed     Text format     Abstract available


  29. ERKIZAN HV, Johnson K, Ghimbovschi S, Karkera D, et al
    African-American esophageal squamous cell carcinoma expression profile reveals dysregulation of stress response and detox networks.
    BMC Cancer. 2017;17:426.
    PubMed     Text format     Abstract available


  30. VAN GINKEL JH, Huibers MMH, van Es RJJ, de Bree R, et al
    Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
    BMC Cancer. 2017;17:428.
    PubMed     Text format     Abstract available


  31. LONKVIST CK, Lonbro S, Vinther A, Zerahn B, et al
    Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial.
    BMC Cancer. 2017;17:400.
    PubMed     Text format     Abstract available


    May 2017
  32. MAGNUSSEN SN, Hadler-Olsen E, Costea DE, Berg E, et al
    Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - beta1 (TGF-beta1) and potential effects on migration and invasion.
    BMC Cancer. 2017;17:350.
    PubMed     Text format     Abstract available


  33. KULASINGHE A, Perry C, Kenny L, Warkiani ME, et al
    PD-L1 expressing circulating tumour cells in head and neck cancers.
    BMC Cancer. 2017;17:333.
    PubMed     Text format     Abstract available


  34. LONJOU C, Damiola F, Moissonnier M, Durand G, et al
    Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation.
    BMC Cancer. 2017;17:328.
    PubMed     Text format     Abstract available


  35. YOKOTA T, Ogawa T, Takahashi S, Okami K, et al
    Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
    BMC Cancer. 2017;17:314.
    PubMed     Text format     Abstract available


    April 2017
  36. ZHAO H, Wang Y, Wang MJ, Zhang ZH, et al
    Influence of presence/absence of thyroid gland on the cutoff value for thyroglobulin in lymph-node aspiration to detect metastatic papillary thyroid carcinoma.
    BMC Cancer. 2017;17:296.
    PubMed     Text format     Abstract available


  37. LIN CL, Lee WT, Ou CY, Hsiao JR, et al
    Regular recreational physical activity and risk of head and neck cancer.
    BMC Cancer. 2017;17:286.
    PubMed     Text format     Abstract available


  38. WAGNER M, Khoury H, Bennetts L, Berto P, et al
    Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA.
    BMC Cancer. 2017;17:272.
    PubMed     Text format     Abstract available


  39. GREUTER MJ, Schouten CS, Castelijns JA, de Graaf P, et al
    Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using 18F-FDG-PET-CT and/or diffusion-weighted MRI.
    BMC Cancer. 2017;17:256.
    PubMed     Text format     Abstract available


  40. XIONG L, Zeng XL, Guo CK, Liu AW, et al
    Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
    BMC Cancer. 2017;17:254.
    PubMed     Text format     Abstract available


    March 2017
  41. VARADARAJAN VV, Pace EK, Patel V, Sawhney R, et al
    Follicular thyroid carcinoma metastasis to the facial skeleton: a systematic review.
    BMC Cancer. 2017;17:225.
    PubMed     Text format     Abstract available


  42. VAN DEN BOSCH S, Dijkema T, Kunze-Busch MC, Terhaard CH, et al
    Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.
    BMC Cancer. 2017;17:208.
    PubMed     Text format     Abstract available


    February 2017
  43. KE LR, Xia WX, Qiu WZ, Huang XJ, et al
    Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
    BMC Cancer. 2017;17:134.
    PubMed     Text format     Abstract available


    January 2017
  44. MCLAUGHLIN M, Barker HE, Khan AA, Pedersen M, et al
    HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation.
    BMC Cancer. 2017;17:86.
    PubMed     Text format     Abstract available


  45. FENG X, Lin J, Xing S, Liu W, et al
    Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma.
    BMC Cancer. 2017;17:90.
    PubMed     Text format     Abstract available


  46. TU CC, Hsu PK, Chien LI, Liu WC, et al
    Prognostic histological factors in patients with esophageal squamous cell carcinoma after preoperative chemoradiation followed by surgery.
    BMC Cancer. 2017;17:62.
    PubMed     Text format     Abstract available


  47. KAWAI S, Yokota T, Onozawa Y, Hamauchi S, et al
    Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.
    BMC Cancer. 2017;17:59.
    PubMed     Text format     Abstract available


  48. MORITA FH, Bernardo WM, Ide E, Rocha RS, et al
    Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis.
    BMC Cancer. 2017;17:54.
    PubMed     Text format     Abstract available


  49. GOVENDER R, Smith CH, Taylor SA, Barratt H, et al
    Swallowing interventions for the treatment of dysphagia after head and neck cancer: a systematic review of behavioural strategies used to promote patient adherence to swallowing exercises.
    BMC Cancer. 2017;17:43.
    PubMed     Text format     Abstract available


  50. HATOGAI K, Fujii S, Kojima T, Daiko H, et al
    Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma.
    BMC Cancer. 2017;17:36.
    PubMed     Text format     Abstract available


  51. LIN MC, Lin YC, Chen ST, Young TH, et al
    Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo.
    BMC Cancer. 2017;17:18.
    PubMed     Text format     Abstract available


  52. POLAT B, Kaiser P, Wohlleben G, Gehrke T, et al
    Perioperative changes in osteopontin and TGFbeta1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.
    BMC Cancer. 2017;17:6.
    PubMed     Text format     Abstract available


  53. SONG H, Fang F, Valdimarsdottir U, Lu D, et al
    Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study.
    BMC Cancer. 2017;17:2.
    PubMed     Text format     Abstract available


    December 2016
  54. ALI H, Sinnott SJ, Corcoran P, Deady S, et al
    Oral cancer incidence and survival rates in the Republic of Ireland, 1994-2009.
    BMC Cancer. 2016;16:950.
    PubMed     Text format     Abstract available


  55. LI HM, Li P, Qian YJ, Wu X, et al
    A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma.
    BMC Cancer. 2016;16:946.
    PubMed     Text format     Abstract available


    November 2016
  56. LI S, Wang Z, Huang J, Cheng S, et al
    Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    BMC Cancer. 2016;16:877.
    PubMed     Text format     Abstract available


  57. LOOMANS HA, Arnold SA, Quast LL, Andl CD, et al
    Esophageal squamous cell carcinoma invasion is inhibited by Activin A in ACVRIB-positive cells.
    BMC Cancer. 2016;16:873.
    PubMed     Text format     Abstract available


  58. KARATAS OF, Suer I, Yuceturk B, Yilmaz M, et al
    Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens.
    BMC Cancer. 2016;16:853.
    PubMed     Text format     Abstract available


    October 2016
  59. GOMEZ-MILLAN J, Pajares B, Perez-Villa L, Carnero A, et al
    Subcellular localisation of pMEK has a different prognosis in locally advanced head and neck cancer treated with concomitant radiochemotherapy.
    BMC Cancer. 2016;16:829.
    PubMed     Text format     Abstract available


  60. LIU L, Huang P, Wang Z, Chen N, et al
    Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways.
    BMC Cancer. 2016;16:813.
    PubMed     Text format     Abstract available


  61. HSU CC, Huang SF, Wang JS, Chu WK, et al
    Interplay of N-Cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion.
    BMC Cancer. 2016;16:800.
    PubMed     Text format     Abstract available


  62. LIU LT, Chen QY, Tang LQ, Zhang L, et al
    With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control study.
    BMC Cancer. 2016;16:774.
    PubMed     Text format     Abstract available


  63. PETKAR I, Rooney K, Roe JW, Patterson JM, et al
    DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.
    BMC Cancer. 2016;16:770.
    PubMed     Text format     Abstract available


    March 2016
  64. MCNAIR AG, MacKichan F, Donovan JL, Brookes ST, et al
    What surgeons tell patients and what patients want to know before major cancer surgery: a qualitative study.
    BMC Cancer. 2016;16:258.
    PubMed     Text format     Abstract available


  65. LIU SM, Wang HB, Sun Y, Shi Y, et al
    The efficacy of iodine-125 permanent brachytherapy versus intensity-modulated radiation for inoperable salivary gland malignancies: study protocol of a randomised controlled trial.
    BMC Cancer. 2016;16:193.
    PubMed     Text format     Abstract available


    February 2016
  66. HSIEH CH, Shueng PW, Wang LY, Huang YC, et al
    Impact of postoperative daily image-guided intensity-modulated radiotherapy on overall and local progression-free survival in patients with oral cavity cancer.
    BMC Cancer. 2016;16:139.
    PubMed     Text format     Abstract available


  67. KIM R, Ock CY, Keam B, Kim TM, et al
    Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study.
    BMC Cancer. 2016;16:116.
    PubMed     Text format     Abstract available


  68. MOORCRAFT SY, Fontana E, Cunningham D, Peckitt C, et al
    Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study.
    BMC Cancer. 2016;16:112.
    PubMed     Text format     Abstract available


  69. NYHAN MJ, O'Donovan TR, Boersma AW, Wiemer EA, et al
    MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cells.
    BMC Cancer. 2016;16:101.
    PubMed     Text format     Abstract available


    January 2016
  70. NAKASHIMA H, Matsuoka Y, Yoshida R, Nagata M, et al
    Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study.
    BMC Cancer. 2016;16:41.
    PubMed     Text format     Abstract available


  71. SOULIERES D, Aguilar JL, Chen E, Misiukiewicz K, et al
    Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen.
    BMC Cancer. 2016;16:19.
    PubMed     Text format     Abstract available


  72. ZHU G, Lin JC, Kim SB, Bernier J, et al
    Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma.
    BMC Cancer. 2016;16:42.
    PubMed     Text format     Abstract available


  73. HE Y, Wang Y, Shen L, Zhao Y, et al
    Prognostic value of the distance between the primary tumor and brainstem in the patients with locally advanced nasopharyngeal carcinoma.
    BMC Cancer. 2016;16:114.
    PubMed     Text format     Abstract available


  74. LIMA CR, Geraldo MV, Fuziwara CS, Kimura ET, et al
    MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells.
    BMC Cancer. 2016;16:108.
    PubMed     Text format     Abstract available


  75. CHARLES KA, Harris BD, Haddad CR, Clarke SJ, et al
    Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.
    BMC Cancer. 2016;16:124.
    PubMed     Text format     Abstract available


  76. ZENG Q, Shen LJ, Guo X, Guo XM, et al
    Critical weight loss predicts poor prognosis in nasopharyngeal carcinoma.
    BMC Cancer. 2016;16:169.
    PubMed     Text format     Abstract available


  77. BESIC N, Schwarzbartl-Pevec A, Vidergar-Kralj B, Crnic T, et al
    Treatment and outcome of 32 patients with distant metastases of Hurthle cell thyroid carcinoma: a single-institution experience.
    BMC Cancer. 2016;16:162.
    PubMed     Text format     Abstract available


  78. MURAKAMI N, Matsumoto F, Yoshimoto S, Ito Y, et al
    Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
    BMC Cancer. 2016;16:192.
    PubMed     Text format     Abstract available


  79. CHANG L, Huang J, Wang K, Li J, et al
    Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy.
    BMC Cancer. 2016;16:190.
    PubMed     Text format     Abstract available


  80. CHAI RC, Lim Y, Frazer IH, Wan Y, et al
    A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients.
    BMC Cancer. 2016;16:178.
    PubMed     Text format     Abstract available


  81. SAITO M, Kiyozaki H, Obitsu T, Imoto H, et al
    Herpes simplex virus-1 encephalitis induced by chemoradiotherapy and steroids in an esophageal cancer patient: a case report.
    BMC Cancer. 2016;16:233.
    PubMed     Text format     Abstract available


  82. NIU M, Gao D, Wen Q, Wei P, et al
    MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma.
    BMC Cancer. 2016;16:218.
    PubMed     Text format     Abstract available


  83. HUANG JS, Yao CJ, Chuang SE, Yeh CT, et al
    Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction.
    BMC Cancer. 2016;16:245.
    PubMed     Text format     Abstract available


  84. TAN G, Liu Q, Tang X, Kang T, et al
    Diagnostic values of serum cathepsin B and D in patients with nasopharyngeal carcinoma.
    BMC Cancer. 2016;16:241.
    PubMed     Text format     Abstract available


  85. LIU Z, Cheng C, Luo X, Xia Q, et al
    CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma.
    BMC Cancer. 2016;16:238.
    PubMed     Text format     Abstract available


  86. DONNADIEU J, Lachaier E, Peria M, Saidak Z, et al
    Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies.
    BMC Cancer. 2016;16:273.
    PubMed     Text format     Abstract available


  87. PARVATHY M, Sreeja S, Kumar R, Pillai MR, et al
    Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells.
    BMC Cancer. 2016;16 Suppl 1:293.
    PubMed     Text format     Abstract available


  88. MASTERSON L, Winder DM, Ball SL, Vaughan K, et al
    Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
    BMC Cancer. 2016;16:367.
    PubMed     Text format     Abstract available


  89. RADES D, Seidl D, Janssen S, Bajrovic A, et al
    Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers.
    BMC Cancer. 2016;16:437.
    PubMed     Text format     Abstract available


  90. CHEN LH, Hsu WL, Tseng YJ, Liu DW, et al
    Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines.
    BMC Cancer. 2016;16:431.
    PubMed     Text format     Abstract available


  91. LEI Z, Tian D, Zhang C, Zhao S, et al
    Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma.
    BMC Cancer. 2016;16:410.
    PubMed     Text format     Abstract available


  92. MIZUSHIMA T, Ohnishi S, Shimizu Y, Hatanaka Y, et al
    Fluorescent imaging of superficial head and neck squamous cell carcinoma using a gamma-glutamyltranspeptidase-activated targeting agent: a pilot study.
    BMC Cancer. 2016;16:411.
    PubMed     Text format     Abstract available


  93. WU J, Chen QX
    Prognostic and predictive significance of tumor length in patients with esophageal squamous cell carcinoma undergoing radical resection.
    BMC Cancer. 2016;16:394.
    PubMed     Text format     Abstract available


  94. WANG L, Yu X, Li J, Zhang Z, et al
    Prognostic significance of p53 expression in patients with esophageal cancer: a meta-analysis.
    BMC Cancer. 2016;16:373.
    PubMed     Text format     Abstract available


  95. LIGIER K, Dejardin O, Launay L, Benoit E, et al
    Health professionals and the early detection of head and neck cancers: a population-based study in a high incidence area.
    BMC Cancer. 2016;16:456.
    PubMed     Text format     Abstract available


  96. CHEN L, Sun L, Lang Y, Wu J, et al
    Fast-track surgery improves postoperative clinical recovery and cellular and humoral immunity after esophagectomy for esophageal cancer.
    BMC Cancer. 2016;16:449.
    PubMed     Text format     Abstract available


  97. OKELLO S, Churchill C, Owori R, Nasasira B, et al
    Population attributable fraction of Esophageal squamous cell carcinoma due to smoking and alcohol in Uganda.
    BMC Cancer. 2016;16:446.
    PubMed     Text format     Abstract available


  98. CHEUNG CC, Lun SW, Chung GT, Chow C, et al
    MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
    BMC Cancer. 2016;16:495.
    PubMed     Text format     Abstract available


  99. CLEARY JM, Mamon HJ, Szymonifka J, Bueno R, et al
    Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer.
    BMC Cancer. 2016;16:468.
    PubMed     Text format     Abstract available


  100. LENG WD, Wen XJ, Kwong JS, Huang W, et al
    COX-2 rs689466, rs5275, and rs20417 polymorphisms and risk of head and neck squamous cell carcinoma: a meta-analysis of adjusted and unadjusted data.
    BMC Cancer. 2016;16:457.
    PubMed     Text format     Abstract available


  101. HUANG Y, Liang W, Yang Y, Zhao L, et al
    Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab(R)-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma.
    BMC Cancer. 2016;16:464.
    PubMed     Text format     Abstract available


  102. PARK SW, Hah JH, Oh SM, Jeong WJ, et al
    5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells.
    BMC Cancer. 2016;16:458.
    PubMed     Text format     Abstract available


  103. WANG XP, Li XH, Zhang L, Lin JH, et al
    High level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinoma.
    BMC Cancer. 2016;16:516.
    PubMed     Text format     Abstract available


  104. UCHI Y, Takeuchi H, Matsuda S, Saikawa Y, et al
    CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis.
    BMC Cancer. 2016;16:514.
    PubMed     Text format     Abstract available


  105. CHEN LH, Hsu WL, Tseng YJ, Liu DW, et al
    Erratum to: Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines.
    BMC Cancer. 2016;16:595.
    PubMed     Text format    


  106. AULUCK A, Walker BB, Hislop G, Lear SA, et al
    Socio-economic deprivation: a significant determinant affecting stage of oral cancer diagnosis and survival.
    BMC Cancer. 2016;16:569.
    PubMed     Text format     Abstract available


  107. TAN HZ, Wu ZY, Wu JY, Long L, et al
    Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
    BMC Cancer. 2016;16:560.
    PubMed     Text format     Abstract available


  108. HUANG PY, Zeng TT, Ban X, Li MQ, et al
    Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.
    BMC Cancer. 2016;16:669.
    PubMed     Text format     Abstract available


  109. RUBINSTEIN JC, Brown TC, Christison-Lagay ER, Zhang Y, et al
    Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma.
    BMC Cancer. 2016;16:646.
    PubMed     Text format     Abstract available


  110. ZENG Q, Wang J, Lv X, Li J, et al
    Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis.
    BMC Cancer. 2016;16:693.
    PubMed     Text format     Abstract available


  111. LI G, Liu Y, Liu C, Su Z, et al
    Genome-wide analyses of long noncoding RNA expression profiles correlated with radioresistance in nasopharyngeal carcinoma via next-generation deep sequencing.
    BMC Cancer. 2016;16:719.
    PubMed     Text format     Abstract available


  112. TOYOKAWA T, Kubo N, Tamura T, Sakurai K, et al
    The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
    BMC Cancer. 2016;16:722.
    PubMed     Text format     Abstract available


  113. NAKAMURA H, Yano T, Fujii S, Kadota T, et al
    Natural history of superficial head and neck squamous cell carcinoma under scheduled follow-up endoscopic observation with narrow band imaging: retrospective cohort study.
    BMC Cancer. 2016;16:743.
    PubMed     Text format     Abstract available


  114. SCHNEIDER TC, Kapiteijn E, van Wezel T, Smit JW, et al
    (Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challenges.
    BMC Cancer. 2016;16:31.
    PubMed     Text format     Abstract available


  115. THOMSEN H, Chen B, Figlioli G, Elisei R, et al
    Runs of homozygosity and inbreeding in thyroid cancer.
    BMC Cancer. 2016;16:227.
    PubMed     Text format     Abstract available


  116. TITOV SE, Ivanov MK, Karpinskaya EV, Tsivlikova EV, et al
    miRNA profiling, detection of BRAF V600E mutation and RET-PTC1 translocation in patients from Novosibirsk oblast (Russia) with different types of thyroid tumors.
    BMC Cancer. 2016;16:201.
    PubMed     Text format     Abstract available


  117. BRENNAN K, Holsinger C, Dosiou C, Sunwoo JB, et al
    Development of prognostic signatures for intermediate-risk papillary thyroid cancer.
    BMC Cancer. 2016;16:736.
    PubMed     Text format     Abstract available


  118. HARADA K, Ferdous T, Cui D, Kuramitsu Y, et al
    Induction of artificial cancer stem cells from tongue cancer cells by defined reprogramming factors.
    BMC Cancer. 2016;16:548.
    PubMed     Text format     Abstract available


  119. CARLBERG M, Hedendahl L, Ahonen M, Koppel T, et al
    Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data.
    BMC Cancer. 2016;16:426.
    PubMed     Text format     Abstract available


  120. MARITAZ C, Metz C, Baba-Hamed N, Jardin-Szucs M, et al
    Cetuximab-induced aseptic meningitis: case report and review of a rare adverse event.
    BMC Cancer. 2016;16:384.
    PubMed     Text format     Abstract available


  121. VOJTECHOVA Z, Sabol I, Salakova M, Smahelova J, et al
    Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.
    BMC Cancer. 2016;16:382.
    PubMed     Text format     Abstract available


    June 2015
  122. CHENG S, Li J, Liu W, Liu C, et al
    LTA + 252A > G polymorphism is associated with risk of nasal NK/T-cell lymphoma in a Chinese population: a case-control study.
    BMC Cancer. 2015;15:480.
    PubMed     Text format     Abstract available


    April 2015
  123. SLIJEPCEVIC N, Zivaljevic V, Marinkovic J, Sipetic S, et al
    Retrospective evaluation of the incidental finding of 403 papillary thyroid microcarcinomas in 2466 patients undergoing thyroid surgery for presumed benign thyroid disease.
    BMC Cancer. 2015;15:330.
    PubMed     Text format     Abstract available


    January 2015
  124. LIN JH, Jiang CQ, Ho SY, Zhang WS, et al
    Smoking and nasopharyngeal carcinoma mortality: a cohort study of 101,823 adults in Guangzhou, China.
    BMC Cancer. 2015;15:906.
    PubMed     Text format     Abstract available


  125. CHEN YP, Zhang WN, Tang LL, Mao YP, et al
    Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone.
    BMC Cancer. 2015;15:930.
    PubMed     Text format     Abstract available


  126. GUO SS, Tang LQ, Zhang L, Chen QY, et al
    The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy.
    BMC Cancer. 2015;15:977.
    PubMed     Text format     Abstract available


  127. HUEMER F, Melchardt T, Trankenschuh W, Neureiter D, et al
    Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer.
    BMC Cancer. 2015;15:996.
    PubMed     Text format     Abstract available


  128. MAI ZM, Lo CM, Xu J, Chan KP, et al
    Milk consumption in relation to incidence of nasopharyngeal carcinoma in 48 countries/regions.
    BMC Cancer. 2015;15:994.
    PubMed     Text format     Abstract available


  129. HE YQ, Xue WQ, Shen GP, Tang LL, et al
    Household inhalants exposure and nasopharyngeal carcinoma risk: a large-scale case-control study in Guangdong, China.
    BMC Cancer. 2015;15:1022.
    PubMed     Text format     Abstract available


  130. BINAZZI A, Ferrante P, Marinaccio A
    Occupational exposure and sinonasal cancer: a systematic review and meta-analysis.
    BMC Cancer. 2015;15:49.
    PubMed     Text format     Abstract available


  131. MUKHERJEE S, Hurt CN, Gwynne S, Bateman A, et al
    NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
    BMC Cancer. 2015;15:48.
    PubMed     Text format     Abstract available


  132. KACHEL P, Trojanowicz B, Sekulla C, Prenzel H, et al
    Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue.
    BMC Cancer. 2015;15:140.
    PubMed     Text format     Abstract available


  133. MARTINEZ-AGUILAR J, Clifton-Bligh R, Molloy MP
    A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours.
    BMC Cancer. 2015;15:199.
    PubMed     Text format     Abstract available


  134. EVANGELISTI C, de Biase D, Kurelac I, Ceccarelli C, et al
    A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors.
    BMC Cancer. 2015;15:157.
    PubMed     Text format     Abstract available


  135. VERED M, Lehtonen M, Hotakainen L, Pirila E, et al
    Caveolin-1 accumulation in the tongue cancer tumor microenvironment is significantly associated with poor prognosis: an in-vivo and in-vitro study.
    BMC Cancer. 2015;15:25.
    PubMed     Text format     Abstract available


  136. MATEJCIC M, Vogelsang M, Wang Y, Iqbal Parker M, et al
    NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study.
    BMC Cancer. 2015;15:150.
    PubMed     Text format     Abstract available


  137. PAPROTTKA PM, Rosspunt S, Ingrisch M, Cyran CC, et al
    Reducing tumor growth and angiogenesis using a triple therapy measured with Contrast-enhanced ultrasound (CEUS).
    BMC Cancer. 2015;15:373.
    PubMed     Text format     Abstract available


  138. FU T, Bu ZD, Li ZY, Zhang LH, et al
    Neoadjuvant chemoradiation therapy for resectable esophago-gastric adenocarcinoma: a meta-analysis of randomized clinical trials.
    BMC Cancer. 2015;15:322.
    PubMed     Text format     Abstract available


  139. HUANG L, Chen C, Zhang G, Ju Y, et al
    STK33 overexpression in hypopharyngeal squamous cell carcinoma: possible role in tumorigenesis.
    BMC Cancer. 2015;15:13.
    PubMed     Text format     Abstract available


  140. YANG SW, Lee YS, Chang LC, Hwang CC, et al
    Clinical characteristics of narrow-band imaging of oral erythroplakia and its correlation with pathology.
    BMC Cancer. 2015;15:406.
    PubMed     Text format     Abstract available


  141. ZHAO T, Ding X, Chang B, Zhou X, et al
    MTUS1/ATIP3a down-regulation is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinoma.
    BMC Cancer. 2015;15:203.
    PubMed     Text format     Abstract available


  142. SUN Y, Yu W, Sturgis EM, Peng W, et al
    Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.
    BMC Cancer. 2016;16:70.
    PubMed     Text format     Abstract available


  143. FUZIO P, Napoli A, Ciampolillo A, Lattarulo S, et al
    Clusterin transcript variants expression in thyroid tumor: a potential marker of malignancy?
    BMC Cancer. 2015;15:349.
    PubMed     Text format     Abstract available


  144. HUANG FJ, Zhou XY, Ye L, Fei XC, et al
    Follicular thyroid carcinoma but not adenoma recruits tumor-associated macrophages by releasing CCL15.
    BMC Cancer. 2016;16:98.
    PubMed     Text format     Abstract available


  145. YANG S, Kawamura K, Okamoto S, Yamauchi S, et al
    Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression.
    BMC Cancer. 2015;15:464.
    PubMed     Text format     Abstract available


  146. GAVINE PR, Wang M, Yu D, Hu E, et al
    Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma.
    BMC Cancer. 2015;15:454.
    PubMed     Text format     Abstract available


  147. RAMIREZ UD, Nikonova AS, Liu H, Pecherskaya A, et al
    Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization.
    BMC Cancer. 2015;15:436.
    PubMed     Text format     Abstract available


  148. MORI K, Haraguchi S, Hiori M, Shimada J, et al
    Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment.
    BMC Cancer. 2015;15:573.
    PubMed     Text format     Abstract available


  149. HAMMAMI MM, Duaiji N, Mutairi G, Aklabi S, et al
    Case report of severe Cushing's syndrome in medullary thyroid cancer complicated by functional diabetes insipidus, aortic dissection, jejunal intussusception, and paraneoplastic dysautonomia: remission with sorafenib without reduction in cortisol conc
    BMC Cancer. 2015;15:624.
    PubMed     Text format     Abstract available


  150. OWADALLY W, Hurt C, Timmins H, Parsons E, et al
    PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer.
    BMC Cancer. 2015;15:602.
    PubMed     Text format     Abstract available


  151. LI W, Yu Y, Wang H, Yan A, et al
    Evaluation of the prognostic impact of postoperative adjuvant radiotherapy on head and neck mucosal melanoma: a meta-analysis.
    BMC Cancer. 2015;15:758.
    PubMed     Text format     Abstract available


  152. BECKER C, Jick SS, Meier CR, Bodmer M, et al
    No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study.
    BMC Cancer. 2015;15:719.
    PubMed     Text format     Abstract available


  153. PARK SH, Lee B, Lee S, Choi E, et al
    A qualitative study of women's views on overdiagnosis and screening for thyroid cancer in Korea.
    BMC Cancer. 2015;15:858.
    PubMed     Text format     Abstract available


  154. KIM SM, Park KC, Jeon JY, Kim BW, et al
    Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer.
    BMC Cancer. 2015;15:1003.
    PubMed     Text format     Abstract available


  155. KARTAL K, Onder S, Kosemehmetoglu K, Kilickap S, et al
    Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material.
    BMC Cancer. 2015;15:824.
    PubMed     Text format     Abstract available


  156. PANEBIANCO F, Mazzanti C, Tomei S, Aretini P, et al
    The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management.
    BMC Cancer. 2015;15:918.
    PubMed     Text format     Abstract available


  157. KASAIAN K, Wiseman SM, Walker BA, Schein JE, et al
    The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.
    BMC Cancer. 2015;15:984.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: